Renee Bower
About Renee Bower
Renee Bower serves as the Associate Director of Clinical Quality Assurance at Aimmune Therapeutics in Brisbane, CA, a position she has held since 2015. Previously, she worked for 11 years as the Director of Compliance at Amgen from 2003 to 2014.
Work at Aimmune Therapeutics
Renee Bower has been serving as the Associate Director of Clinical Quality Assurance at Aimmune Therapeutics since 2015. In this role, she is responsible for ensuring compliance with regulatory standards and quality assurance processes within clinical trials. Her work contributes to the development of therapies aimed at treating food allergies, aligning with Aimmune's mission to provide innovative solutions in the field of immunotherapy.
Previous Experience at Amgen
Prior to her current position, Renee Bower worked at Amgen from 2003 to 2014, where she held the title of Director of Compliance. During her 11 years at Amgen, she focused on maintaining compliance with industry regulations and enhancing quality assurance practices. Her experience at Amgen provided her with a solid foundation in clinical compliance and quality management.
Education and Expertise
Renee Bower possesses extensive expertise in clinical quality assurance and compliance. Her background includes significant experience in regulatory affairs and quality management systems, which are critical in the pharmaceutical and biotechnology sectors. This expertise supports her current role in overseeing clinical quality assurance at Aimmune Therapeutics.
Professional Background
Renee Bower has built a career in the biotechnology and pharmaceutical industries, focusing on clinical quality assurance and compliance. Her professional journey includes key roles that have equipped her with the skills necessary to navigate complex regulatory environments and ensure the integrity of clinical trials. Bower's experience spans over two decades, reflecting her commitment to quality in clinical research.